Table 1 Demographic, imaging, and behavioral sample characteristics.
From: Serotonin transporter availability in adults with autism—a positron emission tomography study
ASD | Control | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean | SD | Min | Max | n | Mean | SD | Min | Max | p | ||
Demographic | ||||||||||||
Age | 15 | 33.0 | 9.1 | 19.4 | 48.0 | 15 | 33.1 | 9.4 | 22.1 | 49.1 | 0.92 | |
Education (years) | 15 | 13.7 | 3.4 | 9 | 20 | 15 | 16.3 | 4.0 | 11 | 25 | 0.02 | |
WAIS matrix (sp)a | 15 | 12.5 | 4.0 | 4 | 18 | 15 | 12.2 | 3.4 | 5 | 17 | 0.72 | |
Height (cm) | 15 | 177.3 | 9.6 | 161 | 189 | 15 | 179.1 | 8.6 | 167 | 194 | 0.50 | |
Weight (kg) | 15 | 75.8 | 17.0 | 50.6 | 107.7 | 15 | 73.7 | 12.4 | 51 | 109 | 0.59 | |
Imaging | ||||||||||||
Injected activity (MBq) | 15 | 366.5 | 62.6 | 253 | 464 | 15 | 372.0 | 55.1 | 247 | 440 | 0.79 | |
Molar activity (GBq/µmol) | 15 | 228.1 | 85.8 | 73 | 403 | 15 | 241.3 | 73.6 | 106 | 373 | 0.71 | |
Injected mass (µg) | 15 | 0.54 | 0.34 | 0.24 | 1.36 | 15 | 0.46 | 0.19 | 0.20 | 0.99 | 0.51 | |
Ref. region AUC (SUV)b | 15 | 12.1 | 1.96 | 7.8 | 14.4 | 15 | 11.7 | 1.51 | 10.0 | 15.9 | 0.38 | |
Behavioral | ||||||||||||
EYE | 15 | 24.13 | 5.53 | 13 | 30 | 15 | 29.60 | 2.67 | 24 | 33 | 0.005 | |
MASC | 15 | 29.20 | 5.66 | 18 | 37 | 15 | 36.13 | 2.85 | 28 | 40 | <0.001 | |
Faux Pas | 15 | 43.87 | 10.51 | 21 | 57 | 15 | 53.13 | 5.22 | 41 | 60 | 0.005 | |
VF lp | 15 | 35.13 | 11.40 | 10 | 52 | 15 | 49.67 | 15.15 | 24 | 83 | 0.01 | |
VF cp | 15 | 43.00 | 10.74 | 26 | 69 | 15 | 50.67 | 10.27 | 31 | 70 | 0.06 | |
VF sf | 15 | 12.27 | 3.22 | 4 | 16 | 15 | 15.87 | 2.97 | 10 | 20 | 0.004 | |
Tower | 15 | 519.5 | 275.9 | 205 | 1024 | 15 | 453.3 | 178.5 | 222 | 744 | 0.56 | |
CPT | 15 | 0.60 | 0.42 | 0.11 | 1.87 | 15 | 0.87 | 0.44 | 0.22 | 1.8 | 0.06 | |
EFT | 15 | 726.2 | 693.9 | 46 | 2353 | 15 | 468.3 | 198.4 | 151 | 810 | 0.30 | |
FPT | 15 | 226.3 | 80.4 | 131 | 394 | 15 | 213.9 | 93.4 | 80 | 460 | 0.72 | |